Spinocerebellar Ataxia Type 14

Neurology·MeSH: Hyperargininemia

Prevalence

0.1 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Spinocerebellar Ataxia Type 14?

There are 1 clinical trial targeting Spinocerebellar Ataxia Type 14 tracked by BioSniper.

What is the prevalence of Spinocerebellar Ataxia Type 14?

The estimated prevalence of Spinocerebellar Ataxia Type 14 is approximately 0.1 per 100,000 population.

Deep-dive into Spinocerebellar Ataxia Type 14

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Spinocerebellar Ataxia Type 14 — Drugs in Development & Clinical Trials | BioSniper